Sunday, June 17, 2018 11:36:48 AM
And what are we to make wrt advance rewards to management and employees for yet to be realised results? Cant they wait? Or are the results interminably delayed because the data is immature, or that they have failed the primary and secondary endpoints and so their only option is to continue the trial in hopes of a long tail grand slam because they are afraid of sinister big P forces behind the workings of the FDA affecting approval decisions? Further toxic dilutions then await and shareholders would then not be well disposed to agree to these advanced rewards; so better to do so now, at the 4/27 SM, while the getting is good and the publication carrot still dangling in the wind. And the grants are sizeable especially with no results but just unfulfilled promising conclusions.
Doc, with all due respect, I think we have given management the great benefit of the doubt. It is now time for transparency. For example, has management received a clean bill of health as a result of the 90 day investigation that has now been veiled for not 90 but 900 days? Why can't we know what was behind the hold? It's been lifted right? The FDA has not embargoed NWBO from saying anything about it? Or, when will we see the results of the spring refresh? I could go on and on but the silence and lack of transparency has gone on too long. Hiring a PR firm will not fix the underlying perception of management as lacking in credibility and reliability. Management has created its own perception and, importantly, it is not attractive to Wall Street. Lack of positive news due to uncertainties with the indeterminate length of the trial and Linda's stay tuned mantra will continue to weigh on the pps. Finally, as, if and when there is positive news, the pps will recoup itself and again rise to current levels. A five bagger from a nickel is not a very attractive investment story to say the least. It's time for management to change its style and begin communicating--and not through message boards. Instead of being an apologist for management and giving them the impression that all is hunky dory in paradise, which is a disfavour to all shareholders, it's time for a wake up call. Otherwise supporters and investors won't stay tuned for long and will undoubtedly change to another channel. JMHO.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM